Gsk (GSK) Gross Profit (2009 - 2026)

Gsk's Gross Profit history runs 18 years deep, the most recent figure standing at $8.2 billion for Q2 2026.

• In Q2 2026, Gross Profit rose 6.14% year-over-year to $8.2 billion; the TTM figure through Jun 2026 stood at $39.6 billion (up 8.91% YoY), while the FY2025 annual figure was $31.2 billion, up 9.25% from the prior year.
• Gross Profit for Q2 2026 stood at $8.2 billion, up from $7.8 billion in the prior quarter.
• The five-year high for Gross Profit was $15.2 billion in Q4 2025, with the low at $6.0 billion in Q2 2022.
• The 5-year median for Gross Profit is $7.4 billion (2023), against an average of $8.5 billion.
• Peak annual rise in Gross Profit reached 24.33% in 2022, while the deepest fall reached 51.44% in 2022.
• Gsk's Gross Profit stood at $10.8 billion in 2022, then increased by 17.61% to $12.7 billion in 2023, then advanced by 12.5% to $14.3 billion in 2024, then rose by 5.91% to $15.2 billion in 2025, then tumbled by 45.65% to $8.2 billion in 2026.
• Business Quant data shows GSK's Gross Profit at $8.2 billion in Q2 2026, $7.8 billion in Q1 2026, and $15.2 billion in Q4 2025.